USPTO Patent Application: Antibody Conjugates with Bis-MSPT Linker
Summary
The USPTO has published a new patent application (US20260083854A1) detailing antibody conjugates that utilize a bis-MSPT linker. The application, filed by inventors Riazul Alam, Guillermo S. Cortez, and Yan Wang, describes pharmaceutical compositions and methods related to these conjugates.
What changed
This document is a publication of a United States Patent Application (US20260083854A1) filed on September 19, 2025. It describes antibody conjugates incorporating a bis-MSPT linker, along with related pharmaceutical compositions and methods of use. The application lists Riazul Alam, Guillermo S. Cortez, and Yan Wang as inventors.
As this is a patent application, it does not impose direct regulatory obligations or compliance deadlines on regulated entities. However, it may inform future research and development strategies for companies in the pharmaceutical and biotechnology sectors, particularly those involved in antibody-drug conjugates or peptide-based therapeutics.
Archived snapshot
Mar 26, 2026GovPing captured this document from the original source. If the source has since changed or been removed, this is the text as it existed at that time.
CONJUGATES COMPRISING BIS-MSPT LINKER
Application US20260083854A1 Kind: A1 Mar 26, 2026
Inventors
Riazul ALAM, Guillermo S. CORTEZ, Yan WANG
Abstract
Provided herein are antibody conjugates comprising a bis-MSPT linker, pharmaceutical compositions comprising such conjugates, and methods of making or using such conjugates.
CPC Classifications
A61K 47/6807 A61K 9/0019 A61K 47/6849 A61K 47/6889 A61P 25/28 C07K 16/2881
Filing Date
2025-09-19
Application No.
19333454
Named provisions
Related changes
Get daily alerts for USPTO Patent Applications - Peptides (C07K)
Daily digest delivered to your inbox.
Free. Unsubscribe anytime.
Source
About this page
Every important government, regulator, and court update from around the world. One place. Real-time. Free. Our mission
Source document text, dates, docket IDs, and authority are extracted directly from USPTO.
The summary, classification, recommended actions, deadlines, and penalty information are AI-generated from the original text and may contain errors. Always verify against the source document.
Classification
Who this affects
Taxonomy
Browse Categories
Get alerts for this source
We'll email you when USPTO Patent Applications - Peptides (C07K) publishes new changes.
Subscribed!
Optional. Filters your digest to exactly the updates that matter to you.